Borderline ovarian tumors

American Journal of Medicine

Volumn 101, Issue 2, 1996, Pages 217-225

  Link, Charles J ^a  

^a Gene Therapy Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; FEMALE; HIGH RISK POPULATION; HUMAN; OVARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURGICAL TECHNIQUE;

EID: 20644449259     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(96)80079-9     Document Type: Review

References (2)

1. Kaern J, Trope C, Kjorstad KE, et al. Cellular DMA content as a new prognostic tool in patients with borderline tumors of the ovary. Gynecol Oncol. 1990;38:452-457.
2. Goldman TL, Chalas E, Chumas J, et al. Management of borderline tumors of the ovary. South Med J. 1993;86:423-425.